DAGA, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 2298
EU - Europa 1281
AS - Asia 872
SA - Sud America 44
AF - Africa 23
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4535
Nazione #
US - Stati Uniti d'America 2254
CN - Cina 522
IT - Italia 506
IE - Irlanda 120
SE - Svezia 118
JP - Giappone 87
DE - Germania 84
TW - Taiwan 73
FR - Francia 64
GB - Regno Unito 61
PL - Polonia 46
VN - Vietnam 42
DK - Danimarca 36
IN - India 36
KR - Corea 36
CA - Canada 34
FI - Finlandia 33
AT - Austria 31
BR - Brasile 28
ES - Italia 28
UA - Ucraina 28
NL - Olanda 25
BE - Belgio 20
HK - Hong Kong 17
AU - Australia 16
TR - Turchia 14
RU - Federazione Russa 13
CH - Svizzera 12
ET - Etiopia 12
HR - Croazia 10
MX - Messico 10
IR - Iran 9
PT - Portogallo 9
ID - Indonesia 8
RO - Romania 8
TH - Thailandia 7
BG - Bulgaria 6
AR - Argentina 5
MY - Malesia 5
CO - Colombia 4
CZ - Repubblica Ceca 4
GR - Grecia 4
SG - Singapore 4
SN - Senegal 4
BY - Bielorussia 3
CL - Cile 3
EG - Egitto 3
HU - Ungheria 3
IQ - Iraq 3
SI - Slovenia 3
IL - Israele 2
KE - Kenya 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
LB - Libano 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PK - Pakistan 1
QA - Qatar 1
RS - Serbia 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 4535
Città #
Fairfield 276
Torino 222
Chandler 221
Houston 148
Beijing 138
Woodbridge 133
Ashburn 119
Dublin 117
Redwood City 106
Seattle 104
Cambridge 88
Wilmington 85
Ann Arbor 79
Jacksonville 73
Pisa 62
Shanghai 58
Taipei 58
Villeurbanne 45
Dearborn 44
Nyköping 43
Guangzhou 35
Warsaw 33
Medford 32
Nanjing 31
Vienna 29
Princeton 26
Dong Ket 25
Fremont 25
Shenyang 23
San Diego 22
Wuhan 18
Chengdu 16
Hangzhou 14
Jinan 14
Xian 14
Brussels 12
Los Angeles 12
Boston 11
Changsha 11
Hefei 11
Boardman 10
Braunschweig 10
London 10
Milan 10
Napoli 10
Seoul 9
Tianjin 9
Tokyo 9
Zhengzhou 9
Gloucester 8
Kunming 8
Nanchang 8
Ottawa 8
Phoenix 8
Montréal 7
Newcastle 7
Rome 7
Silver Spring 7
Turin 7
Valdagno 7
Berlin 6
Central District 6
Chicago 6
Duncan 6
Hebei 6
New York 6
Polska 6
Renton 6
São Paulo 6
Barcelona 5
Groningen 5
Minneapolis 5
Moscow 5
Norwalk 5
Okayama 5
Osaka 5
Piemonte 5
Piscataway 5
Ripon 5
Toronto 5
Valencia 5
Baltimore 4
Bonn 4
Buenos Aires 4
Buffalo 4
Caserta 4
Chongqing 4
Copenhagen 4
Durham 4
Düsseldorf 4
Fuzhou 4
Gravina In Puglia 4
Guiyang 4
Harbin 4
Madison 4
Mansfield 4
Molise 4
Munich 4
Vila Real 4
Washington 4
Totale 2991
Nome #
Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases. 767
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 517
Drug delivery nanoparticles in treating chemoresistant tumor cells 351
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 295
Drug Delivery Nanoparticles in Skin Cancers 201
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 194
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 178
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage 178
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 168
3D advanced human melanoma models 157
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products 150
Multiple catalytic activities of human 17β-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors. 130
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. 129
In Vitro Modeling of Tissue-Specific 3D Microenvironments and Possibile Application to Pediatric Cancer Research 123
The Potential Therapeutic Target Nrf2 in Childhood Brain Tumors 122
Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines 121
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression 119
3D advanced melanoma models 102
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 86
Latest News on Nanotechnology for Melanoma Therapy and Diagnosis 83
Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders 82
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity 82
DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity 82
Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver 75
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer 66
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells 54
GSH-responsive nanoparticles in the treatment of tumor cells. 53
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 16
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 11
Totale 4692
Categoria #
all - tutte 6313
article - articoli 0
book - libri 0
conference - conferenze 539
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018315 0000 00 057 128634720
2018/2019765 38375238 4829 3087 5584160107
2019/20201004 71514795 61123 99128 122835470
2020/2021966 55726563 8075 7974 1138311097
2021/2022648 43393457 3540 3422 556614182
2022/2023546 68782485 53193 450 0000
Totale 4692